Search For "drl"
Fermenta Biotech Limited exclusively licenses its proprietary enzymatic te
Updated : 5 months ago IST
New Delhi [India], January 21 (ANI/PNN): Fermenta Biotech Limited (FBL) today announced that it has signed a Definitive Agreement with Aurigene Pharmaceutical Services Limited (APSL), a stepdown subsidiary of Dr Reddy's Laboratories Limited (DRL).
Read More
DRDO's anti-COVID drug priced at Rs 990 per sachet; Centre, states to get
Updated : 1 year ago IST
New Delhi [India], May 28 (ANI): Defence Research and Development Organisation's (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy's Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to Centre and state
Read More
Dr Reddy's Lab submits revised protocol to DCGI to conduct phase 2,3 clini
Updated : 1 year, 8 months ago IST
New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised application to the Drugs Controller General of India (DCGI) seeking his approval to conduct phase 2 and 3 clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a governm
Read More
DCGI directs Dr Reddy's lab to furnish fresh protocol to seek approval for
Updated : 1 year, 8 months ago IST
New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert panel has directed the pharma giant Dr Reddy's Laboratories (DRL) to submit a revised protocol for performing phase 2,3 clinical trials of the Russian COVID-19 vaccine (Sputnik
Read More
Dr Reddy's Laboratories seeks DCGI permission to conduct Phase III trials
Updated : 1 year, 8 months ago IST
New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an application to the Drugs Controller General of India (DCGI) for its approval to perform Phase III clinical trials of the Russian COVID-19 vaccine Sputnik V in India, a government officia
Read More
Ind-Ra assigns A1-plus rating to Dr Reddy's commercial papers
Updated : 2 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 2 (ANI): India Ratings and Research (Ind-Ra) has accorded AA-plus rating to Dr Reddy's Laboratories Ltd's (DRL's) long-term issuer rating with stable outlook and A1-plus to commercial papers.
Read More
